PDHA2 Antikörper (N-Term)
Kurzübersicht für PDHA2 Antikörper (N-Term) (ABIN928694)
Target
Alle PDHA2 (PDHa2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- PDHA2 antibody was raised in rabbit using the N terminal of PDHA2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PDHA2 Blocking Peptide, catalog no. 33R-8060, is also available for use as a blocking control in assays to test for specificity of this PDHA2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PDHA2 (PDHa2) (Pyruvate Dehydrogenase (Lipoamide) alpha 2 (PDHa2))
-
Andere Bezeichnung
- PDHA2
-
Hintergrund
- The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO2. It contains multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). Synonyms: Polyclonal PDHA2 antibody, Anti-PDHA2 antibody, pyruvate dehydrogenase, lipoamide alpha 2 antibody, MGC149517 antibody, MGC149518 antibody, PDHAL antibody.
-
Pathways
- Warburg Effekt
Target
-